NASDAQ Companies

Issues guidance following a transformative year with the Company adding two new business lines, significantly strengthening the Balance Sheet and […]

LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced financial […]

Confirms Receipt of Two Director Nominees from Daniel J. Mangless Stockholders Are Not Required to Take Action at This Time […]

JACKSONVILLE, Fla., March 31, 2025 (GLOBE NEWSWIRE) — FRP Holdings, Inc. (NASDAQ: FRPH) announced today several updates regarding its investor […]

Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple milestones anticipated in 2025 […]

CLAYMONT, Del., March 31, 2025 (GLOBE NEWSWIRE) — Archimedes Tech SPAC Partners II Co. (Nasdaq: ATIIU) (the “Company”) today announced […]

Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome […]

-Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain (“CINP”) Phase 2b Trial – – […]

CAMARILLO, Calif., March 31, 2025 (GLOBE NEWSWIRE) — via IBN – Newton Golf Company (Nasdaq: NWTG), a developer of performance-focused […]

SUNNYVALE, Calif., March 31, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the […]